Interim Report Third Quarter 2022
STENOCARE A/SNASDAQ FIRST NORTH GROWTH MARKET, DENMARKTICKER: STENO STENOCARE A/S (“STENOCARE”) today announces its results for the period 01.01.2022 – 30.09.2022. The report, which has not been reviewed by the Company’s auditors, is attached to this release and is also available on https://stenocare.com/investor-relations/Thomas Skovlund Schnegelsberg, CEO of STENOCARE, comments: Q3 2022 marked several milestones that will help us grow sales and our leadership role during 2023 and onwards. We entered two new countries with medical cannabis oil products, we had another product